Hemp-derived cannabinoids, such as cannabidiol (CBD), are compounds derived from hemp plants and used to treat various ailments. The sale of these products is regulated on a state-by-state basis; in Tennessee, Senate Bill 378 has recently passed through the House and the Senate and has since been sent to Governor Bill Lee’s (R) desk in hopes of being signed into law, providing new regulations for the sale of hemp-derived cannabinoids.
While this legislation provides access to hemp-derived cannabinoid products for Tennesseans, it is important to recognize that due to the lack of an adult use or medical cannabis program in Tennessee, these regulations are the most likely and safest way for residents of the state to access this type of medication.
Senate Bill 378 provides new regulations for the sale of hemp-derived cannabinoids and was approved by both houses of the Tennessee General Assembly. The 2018 U.S. Farm Bill defines hemp as having less than 0.3% delta-9 tetrahydrocannabinol (THC), the psychoactive component in cannabis plants; as such, hemp-derived cannabinoids contain little to no THC and have been used to address a variety of medical ailments.
The bill imposes a privilege tax on manufacturers or sellers of these products, requires that they be kept behind the counter in an area inaccessible to customers, purchasers must be 21 and older, and mandates that all packaging must include cautions about potential intoxicating effects if used and warnings regarding possible interactions with certain medications. Additionally, it requires retailers to appropriately store any records related to hemp extract transactions; failure to do so may result in criminal penalties.
The purpose of this legislation is to ensure proper regulation and taxation of hemp-derived cannabinoid products while also protecting consumers from potential risks associated with use. If Governor Lee signs this bill into law, it will provide access to hemp-derived cannabinoid products for Tennesseans and create a regulated industry for the sale of these products.
Potential Health Benefits of Hemp-Derived Cannabinoids for Tennessee Medical Patients
Hemp-derived cannabinoids have been studied as potential treatments for various medical ailments, including chronic pain, depression, and anxiety. Research on the effects of these products is ongoing, but initial studies suggest that they may be effective in alleviating specific symptoms.
Furthermore, hemp-derived cannabinoid products do not contain significant amounts of THC and therefore are unlikely to produce intoxicating effects; this makes them an attractive option for patients seeking relief from their symptoms without the associated psychoactive side effects often associated with cannabis.
If signed into law by Governor Lee, Senate Bill 378 will provide access to these types of products for Tennesseans and could potentially benefit those who suffer from some of the conditions mentioned above. With the passage of this bill, Tennessee medical patients may soon have access to a potential new treatment option.
Potential Economic Benefits For Tennessee With Senate Bill 378
In addition to providing Tennesseans with access to potentially beneficial hemp-derived cannabinoid products, the passage of Senate Bill 378 could also have economic benefits for the state. The bill imposes a privilege tax on manufacturers or sellers of these products, which could increase revenue for the state.
It also requires retailers to appropriately store any records related to hemp extract transactions; this could help ensure that taxes are properly paid and collected on all sales of these products. This additional tax revenue could fund various programs in Tennessee and provide additional resources for citizens. With its potential financial advantages and health benefits, Senate Bill 378 is a win-win for medical patients and the state of Tennessee.
The passage of Senate Bill 378 could create a new market for hemp-derived cannabinoid products in Tennessee, providing new opportunities for businesses. Retailers would be able to sell these products as long as they comply with the regulations outlined in the bill.
Additionally, manufacturers and distributors of hemp extract products may find entering this newly untapped regulated market beneficial. With proper regulation and taxation, this proposed law could allow businesses to grow and thrive while bringing additional revenue into the state.
Setting a Legal, Regulated Market
Setting up a legal, regulated market for hemp extract products is the safest and most efficient way to ensure that Tennessee residents can access these potentially beneficial treatments.
By establishing strict regulations on manufacturers, distributors, and retailers of hemp-derived cannabinoids, Tennessee can take proactive steps to promote patient safety while providing businesses an opportunity to take advantage of this new market.
Lack of Adult Use or Medical Cannabis Programs in Tennessee
While Senate Bill 378 is an essential step in the right direction, it should be noted outside of small circumstances with being able to purchase out of state that there are still no adult-use or medical cannabis programs currently in place in Tennessee. This means that access to these potentially beneficial treatments is still limited, and patients may need access to the full range of products they need.
However, with this proposed legislation, Tennessee could be taking a step towards creating more comprehensive programs for both adult use and medical purposes. By establishing regulations for hemp extract products now, the state can lay the groundwork for more significant cannabis reform initiatives down the road.
This could provide a much-needed boost to the medical community and economic opportunities for Tennessee businesses.
Enjoyed that first hit? Come chill with us every week at the Friday Sesh for a freshly packed bowl of the week’s best cannabis news!